Friday, March 11, 2016

Valeant Weighed Replacing CEO

Valeant Pharmaceutical’s board explored hiring a new CEO before recommitting last month to Michael Pearson as chief of the controversial drugmaker.

from WSJ.com: US Business http://ift.tt/1LhcL4l
via IFTTT

No comments:

Post a Comment